| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | FK-866 HCl |
|---|
| Description | FK-866 is a selective inhibitor of the nicotinamide pathway dependent NAD+ synthesis, causing NAD+ depletion. Highly specific, non-competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT/NAPRT) for both the substrate complex and the free enzyme (Ki=0.4 nM and Ki?=0.3 nM, respectively). NAD+ depletion by FK-866 directs delayed cell death by apoptosis in Hep-G2 human liver carcinoma cells (IC50=~1 nM). Causes premature senescence in normal human smooth muscle cells, an effect that may be linked to decreased activity of the NAD+-dependent enzyme SIRT1. |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | Activator or Inhibitor |
|---|
| Other Names | NAMPT inhibitor |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | P006-25MG |
|---|
| Price | |
|---|
| Order / More Info | FK-866 HCl from ARBOR ASSAYS, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|